Fertility and Sterility
Volume 91, Issue 3 , Pages 733-738 , March 2009

A high oocyte yield for intracytoplasmic sperm injection treatment is associated with an increased chromosome error rate

  • Thomas Haaf, M.D.

      Affiliations

    • Institute for Human Genetics, Epidemiology and Informatics, Johannes Gutenberg University Mainz, Mainz, Germany
    • Corresponding Author InformationReprint requests: Thomas Haaf, M.D., Institute for Human Genetics, Johannes Gutenberg University Mainz, Langenbeckstrasse 1, Bldg. 601, 55131 Mainz, Germany (FAX: 49-6131-175690).
    • ,
  • Antje Hahn

      Affiliations

    • Institute for Human Genetics, Epidemiology and Informatics, Johannes Gutenberg University Mainz, Mainz, Germany
    • ,
  • Anne Lambrecht

      Affiliations

    • Institute for Human Genetics, Epidemiology and Informatics, Johannes Gutenberg University Mainz, Mainz, Germany
    • ,
  • Bärbel Grossmann, Ph.D.

      Affiliations

    • Institute for Human Genetics, Epidemiology and Informatics, Johannes Gutenberg University Mainz, Mainz, Germany
    • ,
  • Eva Schwaab, M.D.

      Affiliations

    • Human Genetic Practice, Wiesbaden, Germany
    • ,
  • Omar Khanaga, Ph.D.

      Affiliations

    • Fertility Center, Wiesbaden, Germany
    • ,
  • Thomas Hahn, M.D.

      Affiliations

    • Fertility Center, Wiesbaden, Germany
    • ,
  • Achim Tresch, Ph.D.

      Affiliations

    • Institute of Medical Biostatistics, Epidemiology and Informatics, Johannes Gutenberg University Mainz, Mainz, Germany
    • ,
  • Martin Schorsch, M.D.

      Affiliations

    • Fertility Center, Wiesbaden, Germany

Received 13 August 2007 ,Revised 2 January 2008 ,Accepted 3 January 2008.

References 

  1. Andersen AN, Gianaroli L, Felberbaum R, de Mouzon J, Nygren KG. Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE. Hum Reprod. 2005;20:1158–1176
  2. Boue A, Boue J, Gropp A. Cytogenetics of pregnancy wastage. Adv Hum Genet. 1985;14:1–57
  3. Macklon NS, Geraedts JP, Fauser BC. Conception to ongoing pregnancy: the “black box” of early pregnancy loss. Hum Reprod Update. 2002;8:333–343
  4. Griffin DK. The incidence, origin, and etiology of aneuploidy. Int Rev Cytol. 1996;167:263–296
  5. Hassold TJ, Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet. 2001;2:280–291
  6. Rosenbusch B. The incidence of aneuploidy in human oocytes assessed by conventional cytogenetic analysis. Hereditas. 2004;141:97–105
  7. Pellestor F, Andreo B, Anahory T, Hamamah S. The occurrence of aneuploidy in human: lessons from cytogenetic studies of human oocytes. Eur J Med Genet. 2006;49:103–116
  8. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319:189–194
  9. Chitty L. Prenatal screening for chromosome abnormalities. Br Med Bull. 1998;54:839–856
  10. Staessen C, Platteau P, van Asche E, Michiels A, Tournaye H, Camus M, et al. Comparison of blastocyst transfer with and without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod. 2004;19:2849–2858
  11. Munne S. Chromosome abnormalities and their relationship to morphology and development of human embryos. Reprod Biomed Online. 2006;12:234–253
  12. Philipp T, Philipp K, Reiner A, Beer F, Kalousek DK. Embryoscopic and cytogenetic analysis of 233 missed abortions: factors involved in the pathogenesis of developmental defects of early failed pregnancies. Hum Reprod. 2003;18:1724–1732
  13. Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, Verhoeve HR, et al. In vitro fertilization with preimplantation genetic screening. N Engl J Med. 2007;357:9–15
  14. Gesetz zum Schutz von Embryonen (Embryonenschutzgesetz -EschG-) vom 13. Dezember. 1990;BGBI. I S. 2746
  15. Verlinsky Y, Cieslak J, Ivakhenko V, Evsikov S, Wolf G, White M, et al. Chromosomal abnormalities in the first and second polar body. Mol Cell Endocrinol. 2001;183(Suppl 1):S47–S49
  16. Grossmann B, Schwaab E, Khanaga O, Hahn T, Schorsch M, Haaf T. Aneuploidiediagnostik an Polkörpern nach ICSI bei 460 Frauen mit multiplen Fehlgeburten, Implantationsversagen oder erhöhtem mütterlichen Alter. Med Genetik. 2004;16:408–412
  17. Montag M, Limbach N, Sabarstinski M, van der Ven K, Dorn C, van der Ven H. Polar body biopsy and aneuploidy testing by simultaneous detection of six chromosomes. Prenat Diagn. 2005;25:867–871
  18. Pehlivan T, Rubio C, Rodrigo L, Romero J, Remohi J, Simon C, et al. Impact of preimplantation genetic diagnosis on IVF outcome in implantation failure patients. Reprod Biomed Online. 2003;6:232–237
  19. Munne S, Magli C, Adler A, Wright G, de Boer K, Mortimer D, et al. Treatment-related chromosome abnormalities in human embryos. Hum Reprod. 1997;12:780–784
  20. Katz-Jaffe MG, Trounson AO, Cram DS. Chromosome 21 mosaic human preimplantation embryos predominantly arise from diploid conceptions. Fertil Steril. 2005;84:634–643
  21. Baart EB, Martini E, Eijkemans MJ, Van Opstal D, Beckers NG, Verhoeff A, et al. Milder ovarian stimulation reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod. 2007;22:980–988
  22. Beckers NG, Macklon NS, Eijkemans MJ, Fauser BC. Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian ageing. Fertil Steril. 2002;78:291–297
  23. De Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, Klip H, van Leeuwen EE. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril. 2002;77:978–985

 Supported by the Merck Serono Company.

 Conducted in collaboration with the Fertility Center Wiesbaden, a commercial provider of IVF/ICSI services.

PII: S0015-0282(08)00016-2

doi: 10.1016/j.fertnstert.2008.01.012

Fertility and Sterility
Volume 91, Issue 3 , Pages 733-738 , March 2009

Article Tools